Alogliptin Impurity 12 is a pharmaceutical intermediate used in the manufacturing process of alogliptin, a compound for diabetes research. It is a structurally defined chemical with multiple ring systems and functional groups.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 2749281-73-8
N-Acetyl alogliptin
Pharmaceutical intermediate or metabolite
N-Boc Alogliptin
active pharmaceutical ingredient
3-(2-Cyanobenzyl) Alogliptin
pharmaceutical intermediate
Alogliptin Impurity 70
pharmaceutical intermediate for alogliptin
5-Aminopyrazole-4-carboxamide hemisulphate
Pharmaceutical intermediate for allopurinol impurities
N-(4-Oxocyclohexyl)acetamide
pharmaceutical intermediate
(s)-2-(1-aminoethyl)-5-bromophenol hydrochloride
Pharmaceutical intermediate
Glycine tert-butyl ester hydrochloride
Pharmaceutical intermediate for peptide synthesis
N-[(3R)-1-[3-[(2-cyanophenyl)methyl]-1-methyl-2,6-dioxopyrimidin-4-yl]piperidin-3-yl]benzamide
YJMNTJGSDFBRQM-OAQYLSRUSA-N
CN1C(=O)C=C(N(C1=O)CC2=CC=CC=C2C#N)N3CCC[C@H](C3)NC(=O)C4=CC=CC=C4